Loading...
Dear readers,
This week, NEJM Journal Watch covered COVID-19–related topics including subcutaneous injection of monoclonal antibodies to prevent infection, Pfizer-BioNTech vaccine effectiveness in pregnant women, COVID-19 as a risk factor for stroke and myocardial infarction, nasopharyngeal immune responses, and bamlanivimab and etesevimab for outpatients at risk for severe disease.
This information appears on the NEJM Journal Watch COVID-19 page (https://www.jwatch.org/covid-19) and on the New England Journal of Medicine coronavirus site (https://www.nejm.org/coronavirus).
As always, we continue to provide our regular coverage of other important infectious diseases research.